Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
A once-weekly dosing interval may offer several practical advantages, including: Potentially improved patient adherence compared with daily injections an association observed with other once-weekly incretin therapies, though direct adherence data for retatrutide are not yet available Relatively stable plasma drug levels between doses, which may help reduce the peaks and troughs that can contribute to side effects Consistent pharmacodynamic effects throughout the week, supporting sustained appetite suppression and metabolic activity In Phase 2 trials (Jastreboff et al., NEJM , 2023), retatrutide was studied across a range of doses up to 12 mg once weekly, with structured dose-escalation protocols used to improve tolerability a strategy commonly employed with incretin-based therapies to minimise gastrointestinal side effects such as nausea, vomiting, and diarrhoea during initiation
limit stimulants
Thus, treatment should be closely monitored and prandial insulin is not recommended as an initial therapy
If any redness, burning, itching, blistering or irritation is observed at any time throughout the test, do not use the product
Klinic revolutionizes access to weight loss treatment by connecting you with experienced GLP-1 providers near you who specialize in weight management
US$ 28.42
US$ 28.80
US$ 21.53
